Modulation of angiotensin-converting enzyme by nitric oxide

British Journal of Pharmacology

Volumn 124, Issue 2, 1998, Pages 291-298

  Ackermann, A ^a   Fernandez Alfonso M S ^c   De Rojas, R Sánchez ^c   Ortega, T ^c   Paul, M ^b   Gonzalez C ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

AI conversion; Angiotensin converting enzyme; Nitric oxide; Rat carotid artery; Vascular smooth muscle

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN I; DIETHYLAMINE; DIPEPTIDYL CARBOXYPEPTIDASE; ENZYME INHIBITOR; GUANYLATE CYCLASE; LINSIDOMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONOR;

AQUEOUS SOLUTION; ARTERY CONSTRICTION; ARTICLE; BIOCHEMISTRY; CAROTID ARTERY; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME MODIFICATION; ENZYME PURIFICATION; HYDROLYSIS; LUNG; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; VASCULAR ENDOTHELIUM;

EID: 0031837160     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701836     Document Type: Article

References (31)

1. ARNAL, J.F., BATTLE, T., RASETTI, C., CHALLAH, M., COSTEROUSSE, O., VICAUT, E., MICHEL, J.B. & ALHENC-GELAS, F. (1994). ACE in three tunicae of rat aorta: expression in smooth muscle and effect in renovascular hypertension. Am. J. Physiol., 267, H1777-1784.
2. ARNOLD, W.P., MITAL, C.K., KATSUKI, S. & MURAD, F. (1977). Nitric oxide activates guanylate cyclase and increases guanosine 3′ : 5′-cyclic monophosphate levels in various tissue preparations. Proc. Natl. Acad. Sci. U.S.A., 74, 3203-3207.
3. BENNET, B.M., KOBUS, S.M., BRIEN,J. F., NAKATSU, K. & MARKS, G.S. (1986).Requirement for reduced, unliganded hemoprotein for the haemoglobin- and myoblobin-mediated biotransformation of glyceryl trinitrate. J. Pharmacol. Exp. Ther., 237, 629-635.
4. BREDT, D.S. & SNYDER, S.H. (1994). Nitric oxide: a physiologic messenger molecule. Ann. Rev. Biochem., 63, 175-195.
5. CONRAD, K.P. & WHITTEMORE, S.L. (1992). NG-monomethyl-L-arginine and nitroarginine potentiate pressor responsiveness of vasoconstrictors in conscious rats. Am. J. Physiol., 262, R1137-R1144.
6. CUSHMAN. D.W. & CHEUNG, M.S. (1971). Spectophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem. Pharmacol., 20, 1637-1648.
7. DIMMELER. S. & BRUNE, B. (1992). Nitric oxide preferentially stimulates auto-ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase compared to alcohol or lactate dehydrogenase. FEBS Lett., 315, 21-24.
8. EHLERS, M.R.W. & RIORDAN, J.F. (1990). Angiotensin converting enzyme: biochemistry and molecular biology. In Hypertension: Pathophysiology, Diagnosis and Management, ed. Laragh, J.H. & Brenner, B.M. pp. 1217-1231. New York: Raven Press.
9. ERDÖS, E.G. (1990). Angiotensin I converting enzyme and the changes in our concepts through the years. Hypertension. 16, 363-370.
10. FERNÁNDEZ-ALFONSO, M.S., MARTORANA, P.A., LICKA, I., VAN EVEN, P., TROBISCH, D. & PAUL, M. (1997). Early induction of angiotensin I-converting enzyme in rat carotid artery following balloon injury. Hypertension. 30, 272-277.
11. FRIEDLAND, J. & SILVERSTEIN, E. (1976). A sensitive fluorimetric assay for serum angiotensin-converting enzyme. Am. J. Clin. Pathol., 66, 416-424.
12. GARG, U.C. & HASSID, A. (1989). Nitric oxide generating vasodilators and 8-Br-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest., 83, 1774-1777.
13. GARTHWAITE, J., SOUTHAM, E., BOULTON, C.L., NIELSEN, E.B., SCHMIDT, K. & MAYER, B. (1995). Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4,]oxadiazolo[4.3-a]quinoxalin-l-one. Mol. Pharmacol., 48, 184-188.
14. GONZALEZ, C., FERNANDEZ, A., MARTIN, S., MONCADA, S. & ESTRADA, C. (1992). Nitric oxide from endothelium and smooth muscle modulates responses to sympathetic nerve stimulation: implications for endotoxin shock. Biochem. Biophys. Res. Commun., 186, 150-156.
15. GOPALAKRISHNA, R., CHEN. Z.H. & GUNDIMEDA, U. (1993). Nitric oxide and nitric oxide-generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding. J. Biol, Chem., 268, 27180-27185.
16. HIBBS, J.B., TAINTOR, R.R., VAVRIN, Z & RACHLIN, E.M. (1988). Nitric oxide: a cytotoxic activate macrophage effector molecule. Biochem. Biophys. Res. Commun., 157, 87-94.
17. MARAGOS, C.M., MORLEY, D., WINK, D.A., DUNAMS, T.M.. SAAVEDRA. J.E., HOFFMAN, A., BOVE, A.A., ISAAC, L., HRABIE. J.A.& KEEFER, L.K. (1991). Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J. Med. Chem., 34, 3242-3247.
18. G-nitro-L-arginine methyl ester due to converting enzyme inhibition. J. Cardiovasc. Pharmacol., 28, 142-148.
19. MOLINA, Y., VEIDA, L., MCDONALD, B., REEP, B., BRUNE, B., DISILVO, M., BILLIAR, T. & LAPETINA, F.G. (1992). Nitric oxide-induce S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase inhibits enzymatic activity and increases endogenous ADP-ribosylation. J. Biol. Chem., 267, 24929-24932.
20. MONCADA, S., PALMER, R.M.J. & HIGGS, E.A. (1991). Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev., 43, 109-142.
21. MOORADIAN, D.L., HUTSELL, T.C. & KEEFER. L.K. (1995). Nitric-oxide (NO) donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation in vitro. J. Cardiovasc. Pharmacol., 25, 674-678.
22. MORO, M.A., RUSSEL, R.J., CELLEK, S., LISAZOAIN, I., SU. Y., DARLEY-USMAR. V.M., RADOMSKI, M.W. & MONCADA, S. (1996). cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc. Natl. Acad. Sci. U.S.A., 93, 1480-1485.
23. NAKAKI, T., NAKAYAMA, M. & KATO, R. (1990). Inhibition by nitric oxide and nitric-oxide producing vasodilators of DNA synthesis in vascular smooth muscle cells. Eur. J. Pharmacol., 189, 347-353.
24. NOACK, E. & FEELISCH, M. (1989). Molecular aspects underlying the vasodilator action of molsidomine. J. Cardiovasc. Pharmacol., 14 (Suppl. 11), S1-S5.
25. SHAW, A. & VOSPER, A.J. (1997). Solubility of nitric oxide in aqueous and nonaqueous solvents. J. Chem. Soc. Faraday Trans., 8, 1239-1244.
26. SOUBRIER, F., ALHENC-GELAS, F., HUBERT, C., ALLEGRINI, J., JOHN, M., TRGEAR, G. & CORVOL, P. (1988). Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc. Natl. Acad. Sci. U.S.A., 85, 9386 -9390.
27. STAMLER, J.S. SIMON, D.I., OSBORNE, J.A., MULLINS, M.E., JARAKI, O., MICHEL, T., SINGEL, D.J. & LOSCALZO, J. (1992). S-Nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc. Natl. Acad. Sci. U.S.A., 89, 444-448.
28. TAKEMOTO, M., EGASHIRA, K., USUI, M., NUMAGUCHI, K., TOMITA, H., TSUTSUI, H., SHIMOKAWA, H., SUESHI, K. & TAKESHITA. A. (1997). Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxice synthesis in rats. J. Clin. Invest., 99, 278-287.
29. WEI, L., ALHENC-GELAS, F., SOUBRIER, F., MICHAUD, A., CORVOL, P. & CLAUSER, P. (1991). Expression and characterization of recombinant human angiotensin I-converting enzyme. J. Biol. Chem., 266, 5540-5546.
30. WEI, L., CLAUSER, E., ALHENC-GELAS, F. & CORVOL. P. (1992). The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors. J. Biol. Chem., 267, 13398-13403.
31. WINK, D.A., OSAWA, Y., DARBYSHIRE, J.F., JONES, C.R., ESHENAUR, S.C. & NIMS, R. (1993). Inhibition of cytochrome p450 by nitric oxide and a nitric oxide-releasing agent. Arch. Biochem. Biophys., 300, 115-123.